List of Trelstar drug patents
Trelstar is owned by Verity.
Trelstar contains Triptorelin Pamoate.
Trelstar has a total of 1 drug patent out of which 0 drug patents have expired.
Trelstar was authorised for market use on 10 March, 2010.
Trelstar is available in injectable;intramuscular dosage forms.
The generics of Trelstar are possible to be released after 30 June, 2029.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10166181 | VERITY | Slow release pharmaceutical composition made of microgranules |
Jun, 2029
(6 years from now) | |
Drugs and Companies using TRIPTORELIN PAMOATE ingredient
Market Authorisation Date: 10 March, 2010
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic